• 01953 600631
  • 07795 002 003
  • This email address is being protected from spambots. You need JavaScript enabled to view it.


Biomathematica



Funding Required: £200000
Equity Offered: %8

Microbes. Microbes everywhere. They live around and inside us: the human microbiome, our own little ecosystem, plays a key role in our health. Yet it is very hard to access this invisible world. At Biomathematica, we are unlocking the human microbiome using AI to develop the therapeutics of tomorrow
Ghjuvan Grimaud
Founder

SEIS EIS Approved: SEIS

Revenue: I'm making money...

Growth Stage:Seed

Customers:{Customers:value}

The problem we're solving

The human microbiome, the trillions of bacteria that live in our gut and on our skin, plays a key role in our health. Any perturbation of the gut microbiome, for example, can be related to a disease: cancer, inflammations, schizophrenia, alzheimer, etc. There is a need for therapeutics development targeting the human microbiome. Yet, the microbiome is only accessible using genomics data and is a very complex system.


At Biomathematica, we have developed several algorithms to deal with the huge amount of genomics data generated to access this invisible world and to develop the therapeutics of tomorrow. Based on AI, we can stratify patients and simulate microbiomes to develop these new therapeutics.